These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18708435)

  • 21. Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
    Belmonte Serrano MA; Pincus T
    Rheumatology (Oxford); 2010 Sep; 49(9):1795-6; author reply 1796-7. PubMed ID: 20484342
    [No Abstract]   [Full Text] [Related]  

  • 22. The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option.
    El Fassi D; Nielsen CH; Hasselbalch HC; Hegedüs L
    Eur J Endocrinol; 2006 May; 154(5):623-32. PubMed ID: 16645007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
    Salvi M; Vannucchi G; Campi I; Rossi S; Bonara P; Sbrozzi F; Guastella C; Avignone S; Pirola G; Ratiglia R; Beck-Peccoz P
    Eur J Endocrinol; 2006 Apr; 154(4):511-7. PubMed ID: 16556712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion.
    El Fassi D; Nielsen CH; Hasselbalch HC; Hegedüs L
    Thyroid; 2006 Jul; 16(7):709-10. PubMed ID: 16889501
    [No Abstract]   [Full Text] [Related]  

  • 25. Whither TSH receptor blocking antibodies in the treatment of Graves' disease?
    Rapoport B; McLachlan SM
    Thyroid; 2008 Jul; 18(7):695-6. PubMed ID: 18630996
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies.
    El Fassi D; Banga JP; Gilbert JA; Padoa C; Hegedüs L; Nielsen CH
    Clin Immunol; 2009 Mar; 130(3):252-8. PubMed ID: 18964302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiopathic orbital inflammatory disease successfully treated with rituximab.
    Schafranski MD
    Clin Rheumatol; 2009 Feb; 28(2):225-6. PubMed ID: 19015801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cell depletion in Graves' disease: the right answer to the wrong question?
    Smith TJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1620-2. PubMed ID: 17483377
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of adult inflammatory myositis with rituximab: an emerging therapy for refractory patients.
    Majmudar S; Hall HA; Zimmermann B
    J Clin Rheumatol; 2009 Oct; 15(7):338-40. PubMed ID: 20009968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus.
    Hundae A; Peskoe S; Grimsley E; Patel S
    South Med J; 2008 Sep; 101(9):943-4. PubMed ID: 18708978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous pneumomediastinum secondary to refractory dermatomyositis successfully treated with rituximab.
    Lee MA; Hutchinson DG
    Clin Rheumatol; 2010 Aug; 29(8):945-6. PubMed ID: 20195881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritis.
    Blom M; Kievit W; Donders AR; den Broeder AA; Straten VH; Kuper I; Visser H; Jansen TL; Brus HL; Branten AJ; van de Laar MA; van Riel PL
    J Rheumatol; 2011 Nov; 38(11):2355-61. PubMed ID: 21885487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab for the treatment of rheumatoid arthritis.
    Bagust A; Boland A; Hockenhull J; Fleeman N; Greenhalgh J; Dundar Y; Proudlove C; Kennedy T; Moots R; Williamson P; Dickson R
    Health Technol Assess; 2009 Sep; 13 Suppl 2():23-9. PubMed ID: 19804686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.
    Vannucchi G; Covelli D; Currò N; Dazzi D; Maffini A; Campi I; Bonara P; Guastella C; Pignataro L; Ratiglia R; Beck-Peccoz P; Salvi M
    J Clin Endocrinol Metab; 2012 May; 97(5):E755-9. PubMed ID: 22399512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
    Abadoglu O; Epozturk K; Atayik E; Kaptanoglu E
    J Investig Allergol Clin Immunol; 2011; 21(4):319-21. PubMed ID: 21721382
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thrombocytopenia in Graves' disease].
    Schmohl J; Vogel W; Gallwitz B; Möhle R
    Dtsch Med Wochenschr; 2012 May; 137(20):1056. PubMed ID: 22622480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of rituximab on immunocompetency in patients with autoimmune disease.
    Looney RJ; Srinivasan R; Calabrese LH
    Arthritis Rheum; 2008 Jan; 58(1):5-14. PubMed ID: 18163518
    [No Abstract]   [Full Text] [Related]  

  • 38. [Development of psoriasis in a patient with reumatoid arthritis after rituximab].
    Feced Olmos CM; Ivorra Cortés J; Alegre Sancho JJ; Roman Ivorra JA
    Med Clin (Barc); 2014 Jan; 142(1):40-1. PubMed ID: 23510613
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rituximab (Mabthera)--new approach in treatment of rheumatoid arthritis].
    Anić B
    Reumatizam; 2007; 54(2):72-3. PubMed ID: 18351146
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
    Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A
    Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.